Bayview Pharmacy's Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a specially formulated, gel-like semisolid medication. It is dispensed in a tube for easy and controlled application in the vaginal area. This compounded formulation is used to treat conditions such as bacterial vaginosis, candidiasis, trichomoniasis, vulvovaginal atrophy, and vulvovaginitis, providing both therapeutic effects and lubrication for various gynecological purposes.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present our specially compounded vaginal jelly formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026%.
The active ingredients in this formulation, Boric Acid and Hydroxyquinoline Sulfate, work synergistically to combat these conditions. Boric Acid serves as an antiseptic and antifungal agent, inhibiting the growth of bacteria and fungi. Hydroxyquinoline Sulfate, on the other hand, is an antimicrobial agent that aids in reducing inflammation and irritation. Together, these ingredients help alleviate the symptoms associated with the aforementioned gynecological conditions.
This gel-like semisolid formulation is dispensed in a tube for easy and controlled application in the vaginal area. It is designed to deliver medication effectively, while also providing lubrication and therapeutic effects. It is important to note that this formulation should not be used for more than 7 consecutive days, and is not recommended for use by pregnant women.
If you have any questions or concerns about this formulation or its application, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to providing you with the necessary information and guidance to ensure you receive the most appropriate treatment for your gynecological condition.
This compounded formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a specialized treatment designed for various gynecological conditions such as Bacterial Vaginosis, Candidiasis, Trichomoniasis, Vulvovaginal Atrophy, and Vulvovaginitis. It is a gel-like semisolid formulation that is dispensed in a tube for easy and controlled application in the vaginal area. The formulation delivers medication while providing lubrication and therapeutic effects.
It is crucial to note that this formulation is not recommended for use in pregnant women due to potential risks to the fetus. Additionally, patients with known hypersensitivity to any of the ingredients should refrain from using this formulation. If any irritation or adverse reactions occur, it is advised to discontinue use immediately and consult with a healthcare provider.
Patients are advised to use this formulation as directed and to avoid contact with the eyes. It is also recommended to use a condom during treatment as this formulation may reduce the effectiveness of latex condoms. Patients are further advised to abstain from sexual intercourse until the infection is completely cleared to prevent transmission.
If symptoms persist or worsen, it is important to contact a healthcare provider for further evaluation and treatment. This formulation is designed to provide relief and treatment for specific gynecological conditions, and proper use is essential for optimal results.
This compounded formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a specialized treatment designed for a range of vaginal conditions. The unique combination of boric acid and hydroxyquinoline sulfate in this formulation works synergistically to alleviate inflammation and irritation, while also offering antifungal and antibacterial properties.
Boric acid in the formulation helps to lower the pH of the vagina, creating an environment that inhibits the growth of harmful bacteria and fungi. Hydroxyquinoline sulfate, on the other hand, contributes to reducing inflammation and irritation, while also providing antifungal and antibacterial properties. This dual-action approach ensures comprehensive treatment and relief from the symptoms associated with these conditions.
The formulation is dispensed in a gel-like semisolid form, specifically designed for easy and controlled application in the vaginal area. This ensures that the medication is delivered directly to the affected area, providing maximum therapeutic effects. It is crucial to follow the instructions provided by your healthcare provider when using this product to ensure its effectiveness and safety.
Please note that this product should not be used if you are pregnant or breastfeeding. If you have any questions about this formulation or how it works, do not hesitate to reach out to your healthcare provider. They are best equipped to provide you with the necessary information and guidance to ensure the best possible treatment for your condition.
This compounded formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a gel-like semisolid substance, specifically designed for easy and controlled application in the vaginal area. It is primarily used for delivering medication and providing lubrication and therapeutic effects for various gynecological purposes.
However, it is crucial to understand that this formulation should not be used to treat any other conditions apart from those mentioned. It is also not recommended to use this formulation in conjunction with other topical or oral medications.
Patients should be aware that this formulation may cause irritation or a burning sensation upon application. If any of these symptoms occur, it is advised to discontinue use immediately and consult with a healthcare provider. Similarly, prescribers should be cognizant of these potential side effects and advise their patients accordingly.
If you have any queries about this formulation or any other compounding needs, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with all your pharmaceutical needs.
This is a gel-like semisolid formulation that is dispensed in a tube. It is specifically created for easy and controlled application in the vaginal area. It delivers medication and provides lubrication and therapeutic effects for various gynecological purposes.
The purpose of this compounded formulation is to deliver medication to the vaginal area for various gynecological purposes. It also provides lubrication and therapeutic effects.
This vaginal jelly is dispensed in a tube for easy and controlled application. You should follow the instructions provided by your healthcare provider or pharmacist on how to properly use this medication.
The active ingredients in this formulation are Boric Acid at a concentration of 1% and Hydroxyquinoline Sulfate at a concentration of 0.026%.
As with any medication, there may be potential side effects. It is important to discuss these potential side effects with your healthcare provider or pharmacist before starting this medication.
Before using this medication, you should discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Before using this medication with other vaginal products, you should discuss with your healthcare provider or pharmacist to avoid any potential interactions.
You should store this medication as directed by your healthcare provider or pharmacist. Typically, it should be stored at room temperature, away from light and moisture.
If you miss a dose, you should use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
In case of an overdose, you should immediately contact your healthcare provider or local poison control center.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert/apply intravaginally